A BROAD RANGE OF MEDICINES

THERAPEUTIC AREAS​

Intsel Chimos laboratory holds several Marketing Authorizations ('MA') across various therapeutic areas from niche products to higner volumes in order to provide a comprehensive offer to hospitals and pharmacies.

OUR MEDICINES​

We place great importance on the choice of the medicines we market in order to guarantee the quality of our services and thus benefit the patients?

NEW PRODUCTS - RUBRACA®

Since September 4, 2023, we have been the operator and distributor of RUBRACA® (available in 3 presentations RUBRACA® 200mg / RUBRACA® 250mg & RUBRACA® 300mg) indicated in oncology.

You must send your orders by email to:

adv@intselchimos.com

ALPROSTADIL®

We are the owner and exploitant of Alprostadil Intsel Chimos®, which is a prostaglandin analogue.

CUFENCE®​

We are the exploitant of Cufence® which is a drug for the digestive system and metabolism

FARYDAK®​

We are the exploitant of Farydak®, an antineoplastic drug used in cancer treatment.

Do you wish to obtain more information on one of our products ?

CONTACT

NOUVEAUTÉ - Rubraca®